In this podcast, author Dr Kai Hübel discussed a case of a patient with high-risk relapse follicular lymphoma. This discussion outlines the potential effectiveness of chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory follicular lymphoma. This podcast is adapted from a vodcast article published open access in Oncology and Therapy and is fully citeable. The vodcast article features the same audio, but is accompanied by slides and author video. This podcast is published open acc...
Mar 22, 2024•11 min
In this podcast, Elias Jabbour from the University of Texas MD Anderson Cancer Center, Houston, TX, and Matthias Stelljes from the Universitätsklinikum Münster, Münster, Germany summarize and highlight some of the recent findings on the use of inotuzumab ozogamicin as induction therapy for older adults with newly diagnosed acute lymphoblastic leukemia (ALL). This peer-reviewed podcast is published open access in Targeted Oncology and is fully citable. You can access the original published podcas...
Mar 08, 2024•35 min
This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as...
Mar 04, 2024•35 min
This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-023-01093-w. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distrib...
Feb 08, 2024•21 min
In this podcast, we are joined by Professor Sam Seidu who discusses the potential of continuous glucose monitoring (CGM) in managing type 2 diabetes with non-intensive insulin treatment in primary care. This includes a discussion on the evidence for CGM use, the role of primary healthcare in diabetes management, and some practical tips for interpreting the Ambulatory Glucose Profile (AGP) report. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the ...
Jan 15, 2024•28 min
This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-023-00885-z. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, ada...
Nov 24, 2023•22 min
This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States | Neurology and Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 I...
Nov 21, 2023•17 min
In this podcast, Dr Lip and Dr Stambler discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, randomized trial that enrolled adults with electrocardiograph (ECG)-documented PSVT episodes lasting ≥ 20 min. This podcast is published open access in Cardiology and Therapy and is fully citeable. You can access the original published podcast article throug...
Nov 15, 2023•28 min
In this podcast, Xiuning Le from the University of Texas MD Anderson Cancer Center, Houston, TX, Eric Nadler from the Baylor University Medical Center, Dallas, TX, Daniel Costa from the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and John Heymach from the University of Texas MD Anderson Cancer Center, Houston, TX discuss the use of EGFR tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer harboring uncommon EGFR mutations. This podca...
Oct 04, 2023•42 min
This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-023-02664-1. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution an...
Oct 03, 2023•33 min
This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies | Advances in Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International Li...
Sep 27, 2023•26 min
In this podcast, two oncologists and two patient advocates from the patient advocacy group EGFR Resisters talk about the importance of biomarker testing for patients with non-small cell lung cancer and how this can affect treatment decisions and personalised medicine. The panel discusses what biomarkers are, the processes involved in obtaining biomarker testing, how biomarker information is used, and the importance of waiting for biomarker results prior to determining treatment. The panel also d...
Sep 27, 2023•48 min
This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) | Advances in Therapy (springer.com). All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attri...
Sep 20, 2023•23 min
In this podcast, a healthcare professional discusses germline genetic testing with a patient advocate and answers questions regarding the importance of testing in patients with metastatic breast cancer, with a specific focus on germline or inherited breast cancer susceptibility gene (BRCA) mutations. In the USA, national guidelines recommend that all patients with recurrent or metastatic breast cancer should be offered genetic testing for germline breast cancer susceptibility gene 1 or 2 (BRCA1 ...
Sep 15, 2023•29 min
Brain metastases are especially common in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with a cumulative incidence of over 50% and associated with a poor prognosis, high symptom burden, and decreased quality of life. In this podcast, authors discuss the clinical significance of controlling the onset of brain metastases, considerations in selecting a first-line therapy option, efficacy and safety observed in patients with and without brain metastases, and rational...
Aug 14, 2023•37 min
With recent advancements in medical treatments for metastatic renal cell carcinoma (mRCC), increased treatment efficiency may also come with increased toxicity. In this podcast, authors discuss the appropriate management of the adverse events that result from drug toxicity in order to achieve optimal oncological outcomes for their patients whilst still maintaining their quality of life. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the origina...
Jul 13, 2023•17 min
This podcast covers the recent developments in the treatment of metastatic renal cell carcinoma (mRCC) and the ongoing phase 3 trials in this space. Whilst reflecting on these data, as well as the current ESMO guidelines, authors discuss how to choose the appropriate treatment for individualized treatment journeys for patients and talk through the strengths and weaknesses of first-line therapy options. This podcast is published open access in Advances in Therapy and is fully citeable. You can ac...
Jul 12, 2023•26 min
This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast | SpringerLink All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, ...
Jun 27, 2023•27 min
This podcast is published open access in NETH and is fully citeable. You can access the original published podcast article through the NETH website and by using this link: https://link.springer.com/article/10.1007/s40120-023-00506-4 All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or...
Jun 27, 2023•20 min
In this podcast, the authors summarize and highlight some of the T cell–redirecting bispecific antibodies (BsAb) currently in development for the treatment of relapsed/refractory multiple myeloma with a focus on the data reported at the oral session for BsAb at the American Society of Hematology’s 2022 meeting from clinical phase 1 and 2 studies. The six presentations reported the latest safety and efficacy data for the BsAb: talquetamab, elranatamab, teclistamab, forimtamig, and alnuctamab. Thi...
Jun 20, 2023•50 min
In this podcast, experts discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease. Strategies to increase vaccine coverage are also discussed. This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/arti...
Jun 13, 2023•23 min
In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional. Here, the authors discuss the importance of involving patients in the design of clinical trials, as well as strategies to improve dialogue and connections between clinicians, researchers and patients. This podcast is published open access in Oncology and Therapy and is ful...
Jun 07, 2023•31 min
This podcast covers topics including the metastatic renal cell carcinoma landscape with a focus on immune-oncology (IO) agents and tyrosine kinase inhibitors, axitinib indication (combination and monotherapy), a summary of efficacy and safety data, dose modification guidelines, and author experience of managing patients with the most common adverse events (AEs) encompassing prior to initiating therapy, patient education, and follow-up. This podcast is published open access in Advances in Therapy...
May 31, 2023•32 min
In this podcast, Adam Brufsky from the UPMC Hillman Cancer Center, Magee-Women’s Hospital, University of Pittsburgh Medical Center in Pittsburgh, and Christopher Gallagher from the Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC discuss how real-world data in heterogeneous patient populations can complement clinical trial data in informing treatment decision making for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/H...
May 06, 2023•16 min
In this podcast, Aditya Bardia from the Massachusetts General Hospital, Harvard Medical School in Boston, and Giuseppe Viale from the Department of Pathology and Laboratory Medicine at the European Institute of Oncology in Milan discuss HER2-low breast cancer, including the implications of the recent US FDA and EU approval of trastuzumab deruxtecan (T-DXd) for use in patients with HER2-low breast cancer, the new challenges that this development presents, and ongoing research that will help refin...
May 03, 2023•28 min
In this podcast article, nurse practitioners discuss multimodal strategies that enable appropriate conversations to meet patients’ needs through the following four techniques: patient-centric language, teach-back, open-ended questions, and active listening and paraphrasing. These techniques are incorporated into example patient–provider conversations to demonstrate their effectiveness in clinical practice. Comprehensive patient conversations and optimizing patient interactions builds a trustwort...
Mar 14, 2023•22 min
In this podcast, authors Pamela Kushner and Anne Dalin provide a patient and a clinician discussion on a lived experience of the diagnosis of type 2 diabetes, and the importance of patient education for understanding and managing type 2 diabetes and its complications. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/1...
Mar 06, 2023•18 min
In this podcast, Thomas John from the Department of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Margarita Majem from the Department of Medical Oncology at the Hospital de la Santa Creu i Sant Pau in Barcelona, Diane Legg, founder of LUNGSTRONG, and Jonathan Goldman from the David Geffen School of Medicine at the University of California in Los Angeles discuss health-related quality of life in resectable EGFR-mutant non-small cell lung cancer. This podcast is published ope...
Dec 22, 2022•39 min
This podcast with Nick Oliver from Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London discusses real-world data from glucose sensing technologies in type 1 diabetes. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-022-01331-y. All conflicts of interest ca...
Dec 13, 2022•27 min
This podcast with Sanjay Kalra from Department of Endocrinology at Bharti Hospital and Vaishali Deshmukh from Deenanath Mangeshkar Hospital discuss Mind–Body Medicine in Diabetes Management. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-022-01305-0. All conflicts of interest can be found online. Open...
Sep 01, 2022•31 min
